Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Erdosteine in the Long-term Therapy of Chronic Obstructive Pulmonary Disease (COPD). A 12-month, Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study

NCT01032304 is registered in ClinicalTrials.gov with Edmond Pharma as lead sponsor.

NCT NCT01032304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Erdosteine in the Long-term Therapy of Chronic Obstructive Pulmonary Disease (COPD). A 12-month, Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study
Lead sponsor
Edmond Pharma
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2009
Completion date
September 30, 2015
Enrollment
492 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)